Evidence map›Paper›PMID 40358699›Full record

ArticleUrolithiasis2025

Kidney stones and oxidative stress. Types of papillary renal calculi.

F Grases, A Costa-Bauzá

Abstract read
In one paragraph

Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

F GrasesRenal Lithiasis and Pathological Calcification Group, Research Institute of Health Sciences (IUNICS-IdISBa), University of Balearic Islands, Palma de Mallorca, Spain. fgrases@uib.es.
A Costa-BauzáRenal Lithiasis and Pathological Calcification Group, Research Institute of Health Sciences (IUNICS-IdISBa), University of Balearic Islands, Palma de Mallorca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species can promote the formation of kidney stones, and this process requires the participation of cells associated with the renal papilla. Here, we present a revised interpretation of the characteristics of the different types of renal papillary stones and the possible pathways responsible for their formation. We examined kidney stones from a biobank that contains 15,000 stones and identified five different types of papillary stones. Type I stones are calcium oxalate monohydrate (COM) stones that clearly have Randall's plaque but have no renal tubules near the stone-tissue junction. Type II stones are COM stones that have Randall's plaque and calcified renal tubules around the stone-tissue junction. Type III stones are calcium oxalate dihydrate (COD) stones that have a stone-tissue junction and calcified renal tubules. Type IV stones are COM stones containing important deposits of uric acid and/or Na or K urates that occur around stone-tissue junction, together with apatite phosphate, and may also contain bacterial imprints. Type V stones are small COM calculi that have no hydroxyapatite deposits at the stone-tissue junction. Oxidative stress of papillary tissues can generate heterogeneous nucleants that promote the crystallization of calcium phosphate and calcium oxalate, and urine composition determines the type of papillary stone ultimately develops. An active immune response can limit or prevent the development of these stones by eliminating the intra-tissue hydroxyapatite deposits or promoting the regeneration of the outer uroepithelium.

Indexed as

Kidney CalculiKidney MedullaOxidative StressCalcium OxalateCalcium PhosphatesHumansReactive Oxygen SpeciesUric AcidCalcium OxalateCalcium PhosphatesReactive Oxygen SpeciesUric AcidCalcium oxalateOxidative stressRandall’s plaqueRenal papillary stoneRenal tubular plugs

Identifiers

PMID40358699
PMCPMC12075020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.